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stable angina were included. Inclusion criteria – coronary bifurcation
lesions, RVD  2.5 – 4.5 mm; SB RVD  2.0 mm. Exclusion criteria:
STEMI; LM stenosis; CTOs; lesion of interest located at infarct-related
artery; LVEF < 30%; moderate/severe degree valvular disease; pri-
mary cardiomyopathy; L/RBBB, atrial ﬁbrillation/ﬂutter with no
identiﬁable isoelectric line. Intracoronary ECG was recorded by con-
necting outer end of PCI guidewire with V-unipolar lead of ECG. The
BARI risk score was calculated according to length of the vessels
beyond the lesion divided to total vessel length. Troponin concen-
tration difference (Tn postPCI – Tn prePCI) was divided to BARI
bifurcation lesion score (TnD/BARI).
RESULTS Absolute Tn concentration after PCI increased linearly with
the increase of ischemic zone (residual ischemia presented in SB re-
gion only, MB region only or both on icECG – see ﬁgure). However,
when normalized, there was a signiﬁcant difference in necrosis
amount when ischemic territory increased (SBþMB > MB >>> SB,
p¼.029). At 1-year follow-up, using cut-off of 0.001 of TnD/BARI, there
was a signiﬁcant difference in TLR rates in groups with increased TnD/
BARI ratio – 3/14 (21%) vs. 1/55 (2%), p¼.007, as well as MACEs – 6/14
(43%) vs. 9/55 (16%), p¼.005.
CONCLUSIONS The normalized ratio of Troponin difference to area at
risk for myonecrosis after PCI of coronary bifurcation lesions is asso-
ciated with the amount of residual ischemia at end of procedure and
discriminates patients with increased risk of future adverse events.
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BACKGROUND Recent data from ﬁve-year results of SYNTAX trial
showed superiority of Coronary Artery Bypass Graft (CABG) with
regards to all major outcomes (mortality, MI, MACCE, repeat revas-
cularization) whereas stroke rate was similar to Percutaneous Coro-
nary Revascularization (PCI). We sought to compare ﬁve-year
outcomes of PCI Vs CABG.
METHODS PubMed & Web of Science were searched for English lan-
guage studies up to 1st June 2015 comparing ﬁve-year outcomes of PCI
Vs CABG. Study quality, publication bias & heterogeneity were
assessed. Meta-analysis was performed using DerSimonian-Liard
random effects method. Outcomes were reported for following
groups: PCI Vs CABG, PCI with drug eluting stents (DES) Vs CABG, PCI
Vs CABG in diabetes and PCI with DES Vs CABG in diabetes.
RESULTS 10 studies were identiﬁed (n: PCI 6157 CABG 6029). Age (PCI
66 yrs CABG 64.9 yrs) and gender distribution (Males: PCI 73.4% CABG
77%) were similar. Overall, PCI was associated with worse MAC-
CE(RR 1.53, CI 1.40-1.68, p<0.001), MI(RR 1.48, CI 1.05-2.09, p¼0.02) &
repeat revascularization rates(RR 2.70, CI 2.06-3.55, p<0.001) while
all-cause mortality(RR 1.05, CI 0.90-1.23, p¼0.51), cardiac mortal-
ity(RR 1.20, CI 0.98-1.46, p¼0.07) were similar. Stroke (RR 0.79, CI
0.66-0.95, p¼0.01) was lower with PCI. Use of DES for PCI did not alter
these outcomes while stroke (RR 0.64, CI 0.49-0.85, p¼0.002)
remained higher with CABG. In diabetics, PCI was associated withworse outcomes [all-cause mortality (RR 1.35, CI 1.17-1.56, p<0.001),
cardiac mortality (RR 1.36, CI 1.12-1.66, p¼0.002), MI(RR 2.31, CI 1.79-
2.97, p<0.001), MACCE(RR 1.74, CI 1.45-2.00, p<0.001), repeat
revascularization(RR 3.37, CI 2.96-3.84, p<0.001)] while stro-
ke(RR 0.78, CI 0.53-1.14, p¼0.20) was similar to CABG . Use of DES in
diabetics yielded similar results except for the stroke (RR 0.59, CI
0.42-0.84, p¼0.003) that was higher with CABG.
CONCLUSIONS In unselected patients PCI was associated with worse
outcomes in terms of higher MACCE, MI, revascularization though
stroke favored PCI regardless of the type of stent used. In diabetics
our meta-analysis ﬁndings agreed with SYNTAX trial results favoring
CABG for all major outcomes with similar stroke rate as PCI.
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BACKGROUND Modern randomized controlled trials typically use
composite endpoints. This is only valid if each endpoint is equally
important to patients but few trials document patient preference and
seek the relative importance of components of combined endpoints. If
patients weigh endpoints differentially, our interpretation of trial data
needs to be reﬁned.
METHODS We derive a quantitative, structured tool to determine
the relative importance of each endpoint to patients. We then apply
this tool to data comparing angioplasty with drug-eluting stents to
bypass surgery. The survey was administered to patients undergoing
cardiac catheterization. A meta-analysis comparing CABG to PCI was
then performed using (a) standard MACE and (b) patient-centered
MACE.
RESULTS Patients considered stroke worse than death (stroke
102.319.6%, p<0.01), and MI and repeat revascularization less severe
than death (61.926.8% and 41.9  25.4% respectively p<0.01 for
both). 7 RCTs (5251 patients) were eligible. Meta-analysis demon-
strated that standard MACE occurs more frequently with PCI than
surgery (OR 1.44; 95% CI 1.10 to 1.87; p¼0.007). Re-analysis using
patient-centered MACE found no signiﬁcant difference between PCI
and CABG (OR 1.22, 95% CI 0.97 to 1.53; p¼0.10).
CONCLUSIONS Patients do not consider the constituent endpoints of
MACE equal. We derive a novel patient-centered metric that recog-
nizes and quantiﬁes the differences attributed to each endpoint.
When patient preference data are applied to contemporary trial re-
sults, there is no signiﬁcant difference between PCI and CABG. Re-
sponses from individual patients in clinic could be used to give
individual patients a recommendation that is truly personalized.
